Predictive value of HER2 expression, early response and tumor infiltrating lymphocytes (TILs) on efficacy of de-escalated pertuzumab plus trastuzumab in the neoadjuvant WSG-ADAPT-HER2+/HR-trial

被引：4

作者：

Gluz, Oleg ^{[1
,2
,3
]}

Kolberg-Liedtke, Cornelia ^{[4
]}

Biehl, Claudia ^{[5
]}

Christgen, Matthias ^{[6
]}

Kuemmel, Sherko ^{[7
]}

Grischke, Eva -Maria ^{[8
]}

Augustin, Doris ^{[9
]}

Braun, Michael ^{[10
]}

Potenberg, Jochem ^{[11
]}

Graeser, Monika

Kates, Ronald

Wuerstlein, Rachel ^{[12
,13
]}

Feuerhake, Friedrich ^{[14
]}

Nitz, Ulrike ^{[1
,2
]}

Kreipe, Hans

Harbeck, Nadia ^{[12
,13
]}

机构：

[1] West German Study Grp, Monchengladbach, Germany

[2] Breast Ctr Niederrhein Johanniter Clin, Monchengladbach, Germany

[3] Univ Clin Cologne, Monchengladbach, Germany

[4] Charite Univ Med Berlin, Campus Mitte, Berlin, Germany

[5] City Hosp Dortmund, Westphalian Breast Ctr, Dortmund, Germany

[6] Med Sch Hannover, Inst Pathol, Hannover, Germany

[7] Breast Ctr, Clin Essen Mitte, Essen, Germany

[8] Womens Clin, Univ Clin Tuebingen, Tubingen, Germany

[9] Breast Ctr Ostbayern, DONAUISAR Clin Deggendorf, Deggendorf, Germany

[10] Rotkreuzklinikum Munich, Breast Ctr, Munich, Germany

[11] Evangel Waldkrankenhaus, Dept Oncol, Berlin, Germany

[12] Univ Munich LMU, Breast Ctr, Munich, Germany

[13] CCCLMU, Munich, Germany

[14] Med Sch Hannover, Inst Pathol, Monchengladbach, Germany

来源：

关键词：

D O I：

10.1158/1538-7445.SABCS19-P4-10-05

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P4-10-05

引用

页数：3